Alnylam Pharmaceuticals (ALNY): Q4 EPS of -$0.33 in-line. Revenue of $20.5M (-3.5% Y/Y) misses...

|About: Alnylam Pharmaceuticals,... (ALNY)|By:, SA News Editor
Alnylam Pharmaceuticals (ALNY): Q4 EPS of -$0.33 in-line. Revenue of $20.5M (-3.5% Y/Y) misses by $0.4M. (PR)